The kallikrein-kinin system modulates CD4+ T cell function and contributes to T cell migration into the brain after stroke
Abstract Ischemic stroke elicits a sustained thromboinflammatory response that critically shapes secondary brain injury. The kallikrein-kinin system (KKS) has been identified as the interface of vascular injury and inflammatory processes; however, its role in adaptive immunity remains poorly defined. Here, we show that the KKS is associated with pathogenic CD4 + T cell activation and trafficking. In both ischemic stroke patients and mice subjected to transient middle cerebral artery occlusion (tMCAO), circulating CD4 + T cells exhibited a conserved, activated, and trafficking-competent phenotype characterized by upregulation of adhesion/migration markers, indicating a translationally preserved systemic adaptive immune response. Functionally, serum from stroke mice subacutely treated with a plasma kallikrein (PK)-neutralizing antibody (ɑPK) attenuated CD4 + T cell activation, proliferation, expression of adhesion/migration markers, and pro-inflammatory cytokine production in vitro. PK selectively enhanced CD4 + T cell adhesion and migration, while its downstream metabolite Des-Arg 9 -bradykinin (Des-Arg 9 -BK) induced a pronounced pro-inflammatory, pro-migratory phenotype and potentiated chemokine-driven transendothelial migration in vitro. Strikingly, delayed PK inhibition in vivo was associated with reduced T cell accumulation in the ischemic brain and increased circulating CD4 + T cell frequencies, suggesting impaired central nervous system (CNS) infiltration dynamics. Together, these findings support a role for KKS signaling in shaping neuroimmune interactions after ischemic stroke by enhancing endothelial adhesiveness and facilitating CD4 + T cell migration to the ischemic tissue. By linking thromboinflammation and adaptive immunity, the KKS emerges as a promising therapeutic target to selectively modulate neuroimmune interactions and potentially improve functional recovery after ischemic stroke.
Authors
- Christoph Kleinschnitz (ORCID: https://orcid.org/0000-0002-1650-8875)
- Jasmin Bahr (ORCID: https://orcid.org/0000-0002-0178-2804)
- Steffen Haupeltshofer (ORCID: https://orcid.org/0000-0002-7002-9760)
- Janine Gronewold (ORCID: https://orcid.org/0000-0002-1470-424X)
- Cornelius Deuschl (ORCID: https://orcid.org/0000-0001-9262-7289)
- Egor Dzyubenko (ORCID: https://orcid.org/0000-0001-6901-2163)
- Sina Luppus
- Stine Mencl
- Wiebke Hansen (ORCID: https://orcid.org/0000-0002-6020-0886)
- Jan Buer (ORCID: https://orcid.org/0000-0002-7602-1698)
- Michael Forsting (ORCID: https://orcid.org/0000-0002-5584-9824)
- Nadine Gausmann
- Ana I. Casas
- Astrid M. Westendorf
- Rebecca D. Szepanowski
- Dirk M. Hermann
Institutions
- Lund University (SE)
- Maastricht University (NL)
- Essen University Hospital (DE)
Publication Details
- Journal
- Journal of Neuroinflammation
- Published
- 2026-09-05
- DOI
- https://doi.org/10.1186/s12974-026-04034-4
- Primary Topic
- Coagulation, Bradykinin, Polyphosphates, and Angioedema
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Corona-Stiftung
- Universitätsklinikum Essen
- Deutsche Forschungsgemeinschaft
- Bundesministerium für Bildung und Forschung
- Universität Duisburg-Essen